79 related articles for article (PubMed ID: 18681831)
41. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
[TBL] [Abstract][Full Text] [Related]
42. [Recombinant adenovirus-mediated overexpression of TIMP-1 effectively suppresses hepatocellular carcinoma cell line HepG2 in vitro and in vivo].
Xia D; Xu L; Fu H; Qi XL; Quan Y; Yan LN
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):813-7. PubMed ID: 18396636
[TBL] [Abstract][Full Text] [Related]
43. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
[TBL] [Abstract][Full Text] [Related]
44. Altered tumor growth and metastasis of a T-cell lymphoma in Timp-1 transgenic mice.
Krüger A; Fata JE; Khokha R
Blood; 1997 Sep; 90(5):1993-2000. PubMed ID: 9292534
[TBL] [Abstract][Full Text] [Related]
45. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
[TBL] [Abstract][Full Text] [Related]
46. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration.
Mohammed FF; Pennington CJ; Kassiri Z; Rubin JS; Soloway PD; Ruther U; Edwards DR; Khokha R
Hepatology; 2005 Apr; 41(4):857-67. PubMed ID: 15726641
[TBL] [Abstract][Full Text] [Related]
47. Purification and characterization of bioactive his6-tagged recombinant human tissue inhibitor of metalloproteinases-1 (TIMP-1) protein expressed at high yields in mammalian cells.
Vinther L; Lademann U; Andersen EV; Højrup P; Thaysen-Andersen M; Krogh BO; Viuff B; Brünner N; Stenvang J; Moreira JM
Protein Expr Purif; 2014 Sep; 101():157-64. PubMed ID: 24998777
[TBL] [Abstract][Full Text] [Related]
48. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas.
Nakatsukasa H; Ashida K; Higashi T; Ohguchi S; Tsuboi S; Hino N; Nouso K; Urabe Y; Kinugasa N; Yoshida K; Uematsu S; Ishizaki M; Kobayashi Y; Tsuji T
Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287
[TBL] [Abstract][Full Text] [Related]
49. Paradoxical effects of tissue inhibitor of metalloproteinases 1 gene transfer in collagen-induced arthritis.
Apparailly F; Noël D; Millet V; Baker AH; Lisignoli G; Jacquet C; Kaiser MJ; Sany J; Jorgensen C
Arthritis Rheum; 2001 Jun; 44(6):1444-54. PubMed ID: 11407707
[TBL] [Abstract][Full Text] [Related]
50. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
Bator JM; Cohen RL; Chambers DA
Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
[TBL] [Abstract][Full Text] [Related]
51. Autocrine and paracrine regulation of tissue inhibitor of metalloproteinases, transin, and urokinase gene expression in metastatic and nonmetastatic mammary carcinoma cells.
Korczak B; Kerbel RS; Dennis JW
Cell Growth Differ; 1991 Jul; 2(7):335-41. PubMed ID: 1782152
[TBL] [Abstract][Full Text] [Related]
52. Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer.
Aljada IS; Ramnath N; Donohue K; Harvey S; Brooks JJ; Wiseman SM; Khoury T; Loewen G; Slocum HK; Anderson TM; Bepler G; Tan D
J Clin Oncol; 2004 Aug; 22(16):3218-29. PubMed ID: 15249585
[TBL] [Abstract][Full Text] [Related]
53. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
54. Constitutive expression and secretion of proteases in non-metastatic SP1 mammary carcinoma cells and its metastatic sublines.
Korczak B; Kerbel RS; Dennis J
Int J Cancer; 1991 Jun; 48(4):557-61. PubMed ID: 2045200
[TBL] [Abstract][Full Text] [Related]
55. Plasminogen activator activity of metastatic variants from a murine fibrosarcoma; effect of thrombin in vitro.
Coen D; Bottazzi B; Bini A; Conforti MG; Mantovani A; Mussoni L; Donati MB
Int J Cancer; 1983 Jul; 32(1):67-70. PubMed ID: 6683249
[TBL] [Abstract][Full Text] [Related]
56. Production of plasminogen activator by a primary HSV-2-induced hamster fibrosarcoma and its in vivo derived sublines.
Khidair IA; Teale DM; Potter CW; Rees RC
Cancer; 1986 Apr; 57(8):1522-7. PubMed ID: 3948129
[TBL] [Abstract][Full Text] [Related]
57. Proteolytic and metastatic activities of clones derived from a methylcholanthrene-induced murine fibrosarcoma.
McLaughlin ME; Liener IE; Wang N
Clin Exp Metastasis; 1983; 1(4):359-71. PubMed ID: 6100805
[TBL] [Abstract][Full Text] [Related]
58. Premetastatic niche formation in the liver: emerging mechanisms and mouse models.
Krüger A
J Mol Med (Berl); 2015 Nov; 93(11):1193-201. PubMed ID: 26400831
[TBL] [Abstract][Full Text] [Related]
59. Elevated TIMP-1 expression is associated with a prometastatic phenotype, disease relapse, and poor survival in neuroblastoma.
Paul P; Rellinger EJ; Qiao J; Lee S; Volny N; Padmanabhan C; Romain CV; Mobley B; Correa H; Chung DH
Oncotarget; 2017 Oct; 8(47):82609-82620. PubMed ID: 29137288
[TBL] [Abstract][Full Text] [Related]
60. Opposite effects of tissue inhibitor of metalloproteinases-1 (TIMP-1) over-expression and knockdown on colorectal liver metastases.
Bandapalli OR; Paul E; Schirmacher P; Brand K
BMC Res Notes; 2012 Jan; 5():14. PubMed ID: 22230683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
